Condition
Acute Renal Colic
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 2 (1)
P 4 (3)
Trial Status
Completed5
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06231043Phase 4CompletedPrimary
Diclofenac IM Versus Tramadol IV in Acute Renal Colic, RCT
NCT04441762Phase 2CompletedPrimary
Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management.
NCT03704623Phase 4CompletedPrimary
Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic
NCT01685658Phase 4Withdrawn
Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations
NCT02878148Not ApplicableCompletedPrimary
Conditional Imaging Prescription Strategy for Exploration of Acute Uncomplicated Renal Colic
NCT01339624Not ApplicableCompletedPrimary
Nasal Fentanyl And Renal Colic
Showing all 6 trials